Jacobs Levy Equity Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,497
| Closed | -$133K | – | 999 |
|
|
2024
Q2 | $133K | Hold |
16,497
| – | – | ﹤0.01% | 929 |
|
|
2024
Q1 | $229K | Sell |
16,497
-79,334
| -83% | -$1.1M | ﹤0.01% | 882 |
|
|
2023
Q4 | $586K | Hold |
95,831
| – | – | ﹤0.01% | 805 |
|
|
2023
Q3 | $447K | Sell |
95,831
-83,112
| -46% | -$388K | ﹤0.01% | 825 |
|
|
2023
Q2 | $959K | Buy |
178,943
+80,768
| +82% | +$433K | 0.01% | 701 |
|
|
2023
Q1 | $966K | Buy |
+98,175
| New | +$966K | 0.01% | 702 |
|
|
2020
Q1 | – | Sell |
-77,298
| Closed | -$3.06M | – | 1042 |
|
|
2019
Q4 | $3.06M | Buy |
+77,298
| New | +$3.06M | 0.03% | 465 |
|
|
2019
Q2 | – | Sell |
-32,950
| Closed | -$1.48M | – | 981 |
|
|
2019
Q1 | $1.48M | Buy |
32,950
+12,108
| +58% | +$542K | 0.02% | 577 |
|
|
2018
Q4 | $1M | Buy |
20,842
+1,875
| +10% | +$90K | 0.02% | 598 |
|
|
2018
Q3 | $1.27M | Buy |
18,967
+14,709
| +345% | +$981K | 0.02% | 609 |
|
|
2018
Q2 | $200K | Sell |
4,258
-2,509
| -37% | -$118K | ﹤0.01% | 955 |
|
|
2018
Q1 | $382K | Sell |
6,767
-408
| -6% | -$23K | 0.01% | 820 |
|
|
2017
Q4 | $356K | Buy |
+7,175
| New | +$356K | 0.01% | 819 |
|